0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV60.43%PremiumMay 17, 2024Expiry Date2.83Intrinsic Value100Multiplier-5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ventyx Biosciences Stock Discussion
Obesity Drug - Update & Battle for Skinny
SubQ- $VKTX ph2 results puts the company in driver's seat after showing impressive results both in efficacy and safety
$VKTX has shown twice as much weight loss in 13 weeks what $LLY has done in 12 weeks and what $NVO has shown in 40 plus weeks
In safety, VKTX shown its superiority too vs LLY and NVO
For comparison...
Gapping up
$Oracle(ORCL.US)$ The information technology company saw its stock climb 13.3% due to strong per-share earnings, with adjusted earnings per share of $1.41 surpassing the consensus estimate.
$Kohl's Corp(KSS.US)$ The retailer's shares increased by 2.2% after reporting earnings and revenue that exceeded expectations for the fourth quarter.
$Coinbase(COIN.US)$ The cryptocurrency trading platform's shares...
No comment yet